CortiCare
David Roe's work experience includes serving as the Chief Executive Officer at CortiCare since 2023. Prior to that, they worked as a Healthcare Consultant from 2021 to 2023. David also held various roles at TeamHealth from 2013 to 2021, including Senior Vice President and Executive Director. Before that, they were the Executive Director at THS Physician Partners in 2012 and held multiple roles at Ballad Health from 2000 to 2011, including Corporate Director and Practice Administrator.
David Roe has a Bachelor of Science degree in Business Administration from Milligan College. David also holds an MBA from Vanderbilt University - Owen Graduate School of Management.
This person is not in any teams
This person is not in any offices
CortiCare
1 followers
CortiCare provides continuous EEG Services for the ICU, NICU or EMU using a robust infrastructure of monitoring personnel and reading neurophysiologists. The first nationwide Telemedicine network of registered electroencephalographic technologists (R.EEG.T and CLTM) and neurophysiologists available 24/7, 365 days a year for full-time or gap coverage. Our clinical team provides immediate notification of patient events so physicians can interpret neurocritical care data in real-time. CortiCare is also a leading provider of in-home ambulatory Video-EEG and routine EEG studies. Our CortiCloud server offers secure storage and a web-based interface to access outpatient EEG data anytime. With services provided in more than 20 states, we handle insurance preauthorization, patient scheduling, in-home EEG setup, remote monitoring of the 72-hour study, processing of the study with annotations, support for physician access for daily reports and final report, and long-term study storage. CortiCare is especially prepared, staffed and equipped to support clinical trials that involve collection and processing of EEG recordings for safety or clinical response to therapy. We work with many CRO’s and can assist with protocol design, logistics, and data processing and interpretation for all phases of single-site or multi-site trials. Find out more at www.corticare.com.